{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T06:06:43Z","timestamp":1769321203532,"version":"3.49.0"},"posted":{"date-parts":[[2025,6,26]]},"group-title":"In Review","reference-count":165,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,5,13]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Emerging evidence implicates bacterial infections, including\n                  <italic>Chlamydia pneumoniae<\/italic>\n                  (Cp), a gram-negative obligate intracellular bacterium responsible for community-acquired pneumonia, in Alzheimer\u2019s disease (AD) pathogenesis. However, the involvement of Cp in early and advanced AD in the retina is unknown. Here, we identified the existence and distribution of intracellular Cp inclusions and related NLRP3 inflammasome activation and neurodegeneration in postmortem retinas and brains from 95 human donors. Histological analysis in neuropathologically-confirmed MCI and AD patients compared with cognitively normal individuals (n=70), revealed 2.9-4.1-fold increases of Cp inclusions in AD retinas and brains, respectively, with no significant increases in MCI retinas or brains. Mass spectrometry-based proteomics in additional cohorts (n=30), revealed dysregulated brain and retinal bacterial infection-related proteins and inflammasome-associated pathways. Retinal Cp was strongly linked to A\u03b2\n                  <sub>42<\/sub>\n                  , caspase-1 and NLRP3-inflammasome activation components, as well as cleaved caspase-3\n                  <sup>+<\/sup>\n                  apoptosis and cleaved gasdermin D pyroptotic cell death. Despite increased IBA1\n                  <sup>+<\/sup>\n                  microgliosis in the AD retina, the Cp-associated microglial population was reduced by 62%, suggesting impaired microglial phagocytosis. Higher retinal Cp burden correlated with APOE\u03b54 status, advanced Braak stage, and cognitive decline. Machine learning models revealed that retinal Cp or NLRP3, in combination with retinal A\u03b2\n                  <sub>42<\/sub>\n                  , effectively predicted AD diagnosis, Braak stage, and cognition. These findings suggest that Cp infection contributes to AD dementia but is unlikely to initiate AD pathological changes, whereas elevated retinal NLRP3 may serve as an early AD marker. These results underscore the need for future studies investigating Cp's role in AD dementia and testing early antibiotic or inflammasome-targeting therapies.\n                <\/p>","DOI":"10.21203\/rs.3.rs-6658954\/v1","type":"posted-content","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T07:43:23Z","timestamp":1750923803000},"source":"Crossref","is-referenced-by-count":0,"title":["Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer\u2019s disease retina"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2864-8442","authenticated-orcid":false,"given":"Maya","family":"Koronyo-Hamaoui","sequence":"first","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhakta Prasad","family":"Gaire","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosef","family":"Koronyo","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Vit","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Hutton","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Swerdlow","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Robinson","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieu-Trang","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altan","family":"Rentsendorj","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalita","family":"Subedi","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-5319","authenticated-orcid":false,"given":"Alexander","family":"Ljubimov","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lon S.","family":"Schneider","sequence":"additional","affiliation":[{"name":"University of Southern California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Hawes","sequence":"additional","affiliation":[{"name":"University of Southern California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-969X","authenticated-orcid":false,"given":"Stuart","family":"Graham","sequence":"additional","affiliation":[{"name":"Macquarie University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Gupta","sequence":"additional","affiliation":[{"name":"Macquarie University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Mirzaei","sequence":"additional","affiliation":[{"name":"Macquarie University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Black","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse G.","family":"Meyer","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Arditi","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center- UCLA School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-6127","authenticated-orcid":false,"given":"Timothy","family":"Crother","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"(2024) Alzheimer's disease facts and figures. Alzheimers Dement. May 2024;20(5):3708\u20133821. 10.1002\/alz.13809","DOI":"10.1002\/alz.13809"},{"key":"ref2","article-title":"10 causes of death","author":"The top","year":"2024","unstructured":"The top (2024) 10 causes of death. World Health Organ","journal-title":"World Health Organ"},{"issue":"6","key":"ref3","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1007\/s12035-018-1388-y","article-title":"The Possibility of an Infectious Etiology of Alzheimer Disease","volume":"56","author":"Ashraf GM","year":"2019","unstructured":"Ashraf GM, Tarasov VV, Makhmutovsmall a CA et al (2019) The Possibility of an Infectious Etiology of Alzheimer Disease. Mol Neurobiol Jun 56(6):4479\u20134491. 10.1007\/s12035-018-1388-y","journal-title":"Mol Neurobiol Jun"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-023-00369-7","article-title":"Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview","volume":"26","author":"Catumbela CSG","year":"2023","unstructured":"Catumbela CSG, Giridharan VV, Barichello T, Morales R (2023) Clinical evidence of human pathogens implicated in Alzheimer's disease pathology and the therapeutic efficacy of antimicrobials: an overview. Transl Neurodegener Jul 26(1):37. 10.1186\/s40035-023-00369-7","journal-title":"Transl Neurodegener Jul"},{"issue":"4","key":"ref5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/jmv.1890330403","article-title":"Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains","volume":"33","author":"Jamieson GA","year":"1991","unstructured":"Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF (1991) Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J Med Virol Apr 33(4):224\u2013227. 10.1002\/jmv.1890330403","journal-title":"J Med Virol Apr"},{"issue":"2","key":"ref6","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/1040841X.2021.1876630","article-title":"The role of microbial infection in the pathogenesis of Alzheimer's disease and the opportunity for protection by anti-microbial peptides","volume":"47","author":"Li F","year":"2021","unstructured":"Li F, Hearn M, Bennett LE (2021) The role of microbial infection in the pathogenesis of Alzheimer's disease and the opportunity for protection by anti-microbial peptides. Crit Rev Microbiol Mar 47(2):240\u2013253. 10.1080\/1040841X.2021.1876630","journal-title":"Crit Rev Microbiol Mar"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2018.05.023","author":"Readhead B","year":"2018","unstructured":"Readhead B, Haure-Mirande JV, Funk CC et al (2018) Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. Jul 11. ;99(1):64\u201382 e7. 10.1016\/j.neuron.2018.05.023"},{"issue":"1","key":"ref8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JAD-190765","article-title":"Reevaluating the Microbial Infection Link to Alzheimer's Disease","volume":"73","author":"Schnaider L","year":"2020","unstructured":"Schnaider L, Arnon ZA, Gazit E (2020) Reevaluating the Microbial Infection Link to Alzheimer's Disease. J Alzheimers Dis 73(1):59\u201362. 10.3233\/JAD-190765","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"ref9","doi-asserted-by":"publisher","first-page":"e14462","DOI":"10.1111\/1751-7915.14462","article-title":"Do microbes play a role in Alzheimer's disease?","volume":"17","author":"Williams ZAP","year":"2024","unstructured":"Williams ZAP, Lang L, Nicolas S et al (2024) Do microbes play a role in Alzheimer's disease? Microb Biotechnol Apr 17(4):e14462. 10.1111\/1751-7915.14462","journal-title":"Microb Biotechnol Apr"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3389\/fnagi.2018.00302","article-title":"Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia","volume":"10","author":"Balin BJ","year":"2018","unstructured":"Balin BJ, Hammond CJ, Little CS et al (2018) Chlamydia pneumoniae: An Etiologic Agent for Late-Onset Dementia. Front Aging Neurosci 10:302. 10.3389\/fnagi.2018.00302","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"ref11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00430-010-0162-1","article-title":"Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?","volume":"199","author":"Shima K","year":"2010","unstructured":"Shima K, Kuhlenbaumer G, Rupp J (2010) Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember? Med Microbiol Immunol Nov 199(4):283\u2013289. 10.1007\/s00430-010-0162-1","journal-title":"Med Microbiol Immunol Nov"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1393293","DOI":"10.3389\/fnins.2024.1393293","article-title":"Chlamydia pneumoniae in Alzheimer's disease pathology","volume":"18","author":"Subedi L","year":"2024","unstructured":"Subedi L, Gaire BP, Koronyo Y, Koronyo-Hamaoui M, Crother TR (2024) Chlamydia pneumoniae in Alzheimer's disease pathology. Front Neurosci 18:1393293. 10.3389\/fnins.2024.1393293","journal-title":"Front Neurosci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbi.2019.10.014","article-title":"Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology","volume":"83","author":"Woods JJ","year":"2020","unstructured":"Woods JJ, Skelding KA, Martin KL et al (2020) Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology. Brain Behav Immun Jan 83:22\u201332. 10.1016\/j.bbi.2019.10.014","journal-title":"Brain Behav Immun Jan"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/ADR-170017","article-title":"Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease","volume":"28","author":"Carter CJ","year":"2017","unstructured":"Carter CJ, Genetic (2017) Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer's Disease. J Alzheimers Dis Rep Sep 28(1):125\u2013157. 10.3233\/ADR-170017","journal-title":"J Alzheimers Dis Rep Sep"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s004300050071","article-title":"Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain","volume":"187","author":"Balin BJ","year":"1998","unstructured":"Balin BJ, Gerard HC, Arking EJ et al (1998) Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol Jun 187(1):23\u201342. 10.1007\/s004300050071","journal-title":"Med Microbiol Immunol Jun"},{"issue":"3","key":"ref16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijmm.2008.07.002","article-title":"Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain","volume":"299","author":"Dreses-Werringloer U","year":"2009","unstructured":"Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gerard HC, Whittum-Hudson JA, Hudson AP (2009) Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain. Int J Med Microbiol Mar 299(3):187\u2013201. 10.1016\/j.ijmm.2008.07.002","journal-title":"Int J Med Microbiol Mar"},{"issue":"3","key":"ref17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1574-695X.2006.00154.x","article-title":"Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain","volume":"48","author":"Gerard HC","year":"2006","unstructured":"Gerard HC, Dreses-Werringloer U, Wildt KS et al (2006) Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain. FEMS Immunol Med Microbiol Dec 48(3):355\u2013366. 10.1111\/j.1574-695X.2006.00154.x","journal-title":"FEMS Immunol Med Microbiol Dec"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1471-2202-11-121","article-title":"Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain","volume":"11","author":"Hammond CJ","year":"2010","unstructured":"Hammond CJ, Hallock LR, Howanski RJ, Appelt DM, Little CS, Balin BJ (2010) Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain. BMC Neurosci Sep 23 11:121. 10.1186\/1471-2202-11-121","journal-title":"BMC Neurosci Sep 23"},{"issue":"3","key":"ref19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3233\/JAD-140621","article-title":"Bacterial infection and Alzheimer's disease: a meta-analysis","volume":"43","author":"Maheshwari P","year":"2015","unstructured":"Maheshwari P, Eslick GD (2015) Bacterial infection and Alzheimer's disease: a meta-analysis. J Alzheimers Dis 43(3):957\u2013966. 10.3233\/JAD-140621","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"ref20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s00415-006-0298-5","article-title":"Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia","volume":"254","author":"Paradowski B","year":"2007","unstructured":"Paradowski B, Jaremko M, Dobosz T, Leszek J, Noga L (2007) Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia. J Neurol Feb 254(2):154\u2013159. 10.1007\/s00415-006-0298-5","journal-title":"J Neurol Feb"},{"issue":"5","key":"ref21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/psyg.12163","article-title":"Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and vascular dementia","volume":"16","author":"Manabe T","year":"2016","unstructured":"Manabe T, Mizukami K, Akatsu H et al (2016) Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and vascular dementia. Psychogeriatrics Sep 16(5):305\u2013314. 10.1111\/psyg.12163","journal-title":"Psychogeriatrics Sep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"701899","DOI":"10.3389\/fnagi.2021.701899","article-title":"Association Between Antibiotic Treatment of Chlamydia pneumoniae and Reduced Risk of Alzheimer Dementia: A Nationwide Cohort Study in Taiwan","volume":"13","author":"Ou H","year":"2021","unstructured":"Ou H, Chien WC, Chung CH et al (2021) Association Between Antibiotic Treatment of Chlamydia pneumoniae and Reduced Risk of Alzheimer Dementia: A Nationwide Cohort Study in Taiwan. Front Aging Neurosci 13:701899. 10.3389\/fnagi.2021.701899","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1038\/s41598-022-06749-9","article-title":"Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer's disease risk","volume":"17","author":"Chacko A","year":"2022","unstructured":"Chacko A, Delbaz A, Walkden H et al (2022) Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer's disease risk. Sci Rep Feb 17(1):2759. 10.1038\/s41598-022-06749-9","journal-title":"Sci Rep Feb"},{"issue":"5","key":"ref24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.neurobiolaging.2003.12.021","article-title":"Infiltration of the brain by pathogens causes Alzheimer's disease","volume":"25","author":"Itzhaki RF","year":"2004","unstructured":"Itzhaki RF, Wozniak MA, Appelt DM, Balin BJ (2004) Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging May-Jun 25(5):619\u2013627. 10.1016\/j.neurobiolaging.2003.12.021","journal-title":"Neurobiol Aging May-Jun"},{"issue":"4","key":"ref25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0197-4580(03)00127-1","article-title":"Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB\/c mice","volume":"25","author":"Little CS","year":"2004","unstructured":"Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB\/c mice. Neurobiol Aging Apr 25(4):419\u2013429. 10.1016\/S0197-4580(03)00127-1","journal-title":"Neurobiol Aging Apr"},{"issue":"3","key":"ref26","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1007\/s12035-012-8320-7","article-title":"Infectious agents and neurodegeneration","volume":"46","author":"Chiara G","year":"2012","unstructured":"De Chiara G, Marcocci ME, Sgarbanti R et al (2012) Infectious agents and neurodegeneration. Mol Neurobiol Dec 46(3):614\u2013638. 10.1007\/s12035-012-8320-7","journal-title":"Mol Neurobiol Dec"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fnagi.2014.00304","article-title":"Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB\/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae","volume":"6","author":"Little CS","year":"2014","unstructured":"Little CS, Joyce TA, Hammond CJ et al (2014) Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB\/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Front Aging Neurosci 6:304. 10.3389\/fnagi.2014.00304","journal-title":"Front Aging Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2019.00754","article-title":"Autophagy Limits Inflammasome During Chlamydia pneumoniae Infection","volume":"10","author":"Crother TR","year":"2019","unstructured":"Crother TR, Porritt RA, Dagvadorj J et al (2019) Autophagy Limits Inflammasome During Chlamydia pneumoniae Infection. Front Immunol 10:754. 10.3389\/fimmu.2019.00754","journal-title":"Front Immunol"},{"issue":"6","key":"ref29","doi-asserted-by":"publisher","first-page":"e21477","DOI":"10.1371\/journal.pone.0021477","article-title":"Caspase-1 dependent IL-1beta secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection","volume":"6","author":"Shimada K","year":"2011","unstructured":"Shimada K, Crother TR, Karlin J et al (2011) Caspase-1 dependent IL-1beta secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection. PLoS ONE 6(6):e21477. 10.1371\/journal.pone.0021477","journal-title":"PLoS ONE"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"701282","DOI":"10.3389\/fimmu.2021.701282","article-title":"Activation of NLRP3 Inflammasome and Onset of Alzheimer's Disease","volume":"12","author":"Bai H","year":"2021","unstructured":"Bai H, Zhang Q (2021) Activation of NLRP3 Inflammasome and Onset of Alzheimer's Disease. Front Immunol 12:701282. 10.3389\/fimmu.2021.701282","journal-title":"Front Immunol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"845185","DOI":"10.3389\/fphar.2022.845185","article-title":"The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets","volume":"13","author":"Liang T","year":"2022","unstructured":"Liang T, Zhang Y, Wu S, Chen Q, Wang L (2022) The Role of NLRP3 Inflammasome in Alzheimer's Disease and Potential Therapeutic Targets. Front Pharmacol 13:845185. 10.3389\/fphar.2022.845185","journal-title":"Front Pharmacol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-023-00674-9","author":"Terzioglu G","year":"2023","unstructured":"Terzioglu G, Young-Pearse TL, Microglial (2023) function, INPP5D\/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease. Mol Neurodegener. Nov 29 ;18(1):89. 10.1186\/s13024-023-00674-9"},{"issue":"1","key":"ref33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41392-020-0145-7","article-title":"NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease","volume":"1","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Dong Z, Song W (2020) NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease. Signal Transduct Target Ther Apr 1(1):37. 10.1038\/s41392-020-0145-7","journal-title":"Signal Transduct Target Ther Apr"},{"issue":"7434","key":"ref34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice","volume":"31","author":"Heneka MT","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A et al (2013) NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP\/PS1 mice. Nature Jan 31(7434):674\u2013678. 10.1038\/nature11729","journal-title":"Nature Jan"},{"issue":"7784","key":"ref35","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising C","year":"2019","unstructured":"Ising C, Venegas C, Zhang S et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature Nov 575(7784):669\u2013673. 10.1038\/s41586-019-1769-z","journal-title":"Nature Nov"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","article-title":"The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease","volume":"11","author":"Saresella M","year":"2016","unstructured":"Saresella M, La Rosa F, Piancone F et al (2016) The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer's disease. Mol Neurodegener Mar 3 11:23. 10.1186\/s13024-016-0088-1","journal-title":"Mol Neurodegener Mar 3"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"879021","DOI":"10.3389\/fnagi.2022.879021","article-title":"The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases","volume":"14","author":"Blevins HM","year":"2022","unstructured":"Blevins HM, Xu Y, Biby S, Zhang S (2022) The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. Front Aging Neurosci 14:879021. 10.3389\/fnagi.2022.879021","journal-title":"Front Aging Neurosci"},{"issue":"8","key":"ref38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson KV","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol Aug 19(8):477\u2013489. 10.1038\/s41577-019-0165-0","journal-title":"Nat Rev Immunol Aug"},{"issue":"1","key":"ref39","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Vande Walle L","year":"2024","unstructured":"Vande Walle L, Lamkanfi M (2024) Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov Jan 23(1):43\u201366. 10.1038\/s41573-023-00822-2","journal-title":"Nat Rev Drug Discov Jan"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"101273","DOI":"10.1016\/j.preteyeres.2024.101273","article-title":"Alzheimer's disease pathophysiology in the Retina","volume":"101","author":"Gaire BP","year":"2024","unstructured":"Gaire BP, Koronyo Y, Fuchs DT et al (2024) Alzheimer's disease pathophysiology in the Retina. Prog Retin Eye Res Jul 101:101273. 10.1016\/j.preteyeres.2024.101273","journal-title":"Prog Retin Eye Res Jul"},{"issue":"2","key":"ref41","doi-asserted-by":"publisher","first-page":"e14567","DOI":"10.1002\/alz.14567","article-title":"Unlocking ocular biomarkers for early detection of Alzheimer's disease","volume":"21","author":"Dave N","year":"2025","unstructured":"Dave N, Lee M, Pavlou H et al (2025) Unlocking ocular biomarkers for early detection of Alzheimer's disease. Alzheimers Dement Feb 21(2):e14567. 10.1002\/alz.14567","journal-title":"Alzheimers Dement Feb"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3389\/fneur.2017.00701","article-title":"Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases","volume":"8","author":"Doustar J","year":"2017","unstructured":"Doustar J, Torbati T, Black KL, Koronyo Y, Koronyo-Hamaoui M (2017) Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases. Front Neurol 8:701. 10.3389\/fneur.2017.00701","journal-title":"Front Neurol"},{"issue":"6","key":"ref43","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer's: exploring disease in the retina","volume":"132","author":"Hart NJ","year":"2016","unstructured":"Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M (2016) Ocular indicators of Alzheimer's: exploring disease in the retina. Acta Neuropathol Dec 132(6):767\u2013787. 10.1007\/s00401-016-1613-6","journal-title":"Acta Neuropathol Dec"},{"issue":"12","key":"ref44","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","article-title":"Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease","volume":"24","author":"Alexandrov PN","year":"2011","unstructured":"Alexandrov PN, Pogue A, Bhattacharjee S, Lukiw WJ (2011) Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease. Neuroreport Aug 24(12):623\u2013627. 10.1097\/WNR.0b013e3283497334","journal-title":"Neuroreport Aug"},{"issue":"7","key":"ref45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.10.7.5","article-title":"ARCAM-1 Facilitates Fluorescence Detection of Amyloid-Containing Deposits in the Retina","volume":"1","author":"Cao KJ","year":"2021","unstructured":"Cao KJ, Kim JH, Kroeger H et al (2021) ARCAM-1 Facilitates Fluorescence Detection of Amyloid-Containing Deposits in the Retina. Transl Vis Sci Technol Jun 1(7):5. 10.1167\/tvst.10.7.5","journal-title":"Transl Vis Sci Technol Jun"},{"issue":"1","key":"ref46","doi-asserted-by":"publisher","first-page":"e12347","DOI":"10.1002\/dad2.12347","article-title":"No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controls","volume":"14","author":"Haan J","year":"2022","unstructured":"den Haan J, Hart de Ruyter FJ, Lochocki B et al (2022) No difference in retinal fluorescence after oral curcumin intake in amyloid-proven AD cases compared to controls. Alzheimers Dement (Amst) 14(1):e12347. 10.1002\/dad2.12347","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"ref47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","article-title":"Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas","volume":"28","author":"Haan J","year":"2018","unstructured":"den Haan J, Morrema THJ, Verbraak FD et al (2018) Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas. Acta Neuropathol Commun Dec 28(1):147. 10.1186\/s40478-018-0650-x","journal-title":"Acta Neuropathol Commun Dec"},{"issue":"1","key":"ref48","doi-asserted-by":"publisher","first-page":"e12109","DOI":"10.1002\/dad2.12109","article-title":"Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline","volume":"12","author":"Dumitrascu OM","year":"2020","unstructured":"Dumitrascu OM, Lyden PD, Torbati T et al (2020) Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline. Alzheimers Dement (Amst) 12(1):e12109. 10.1002\/dad2.12109","journal-title":"Alzheimers Dement (Amst)"},{"issue":"11","key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112926","article-title":"Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study","volume":"28","author":"Dumitrascu OM","year":"2021","unstructured":"Dumitrascu OM, Rosenberry R, Sherman DS et al (2021) Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. Cells Oct 28(11). 10.3390\/cells10112926","journal-title":"Cells Oct"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fnins.2019.00925","article-title":"Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer's Disease Patients, Possible Biomarkers for Early Diagnosis","volume":"13","author":"Grimaldi A","year":"2019","unstructured":"Grimaldi A, Pediconi N, Oieni F et al (2019) Neuroinflammatory Processes, A1 Astrocyte Activation and Protein Aggregation in the Retina of Alzheimer's Disease Patients, Possible Biomarkers for Early Diagnosis. Front Neurosci 13:925. 10.3389\/fnins.2019.00925","journal-title":"Front Neurosci"},{"issue":"1","key":"ref51","doi-asserted-by":"publisher","first-page":"4227","DOI":"10.1038\/s41467-019-12242-1","article-title":"Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease","volume":"17","author":"Hadoux X","year":"2019","unstructured":"Hadoux X, Hui F, Lim JKH et al (2019) Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer's disease. Nat Commun Sep 17(1):4227. 10.1038\/s41467-019-12242-1","journal-title":"Nat Commun Sep"},{"issue":"2","key":"ref52","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00401-022-02525-1","article-title":"Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies","volume":"145","author":"Hart de Ruyter FJ","year":"2023","unstructured":"Hart de Ruyter FJ, Morrema THJ, den Haan J et al (2023) Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies. Acta Neuropathol Feb 145(2):197\u2013218. 10.1007\/s00401-022-02525-1","journal-title":"Acta Neuropathol Feb"},{"issue":"16","key":"ref53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease","volume":"17","author":"Koronyo Y","year":"2017","unstructured":"Koronyo Y, Biggs D, Barron E et al (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease. JCI Insight Aug 17(16). 10.1172\/jci.insight.93621","journal-title":"JCI Insight Aug"},{"issue":"4","key":"ref54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","article-title":"Retinal pathological features and proteome signatures of Alzheimer's disease","volume":"145","author":"Koronyo Y","year":"2023","unstructured":"Koronyo Y, Rentsendorj A, Mirzaei N et al (2023) Retinal pathological features and proteome signatures of Alzheimer's disease. Acta Neuropathol Apr 145(4):409\u2013438. 10.1007\/s00401-023-02548-2","journal-title":"Acta Neuropathol Apr"},{"issue":"Suppl 1","key":"ref55","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"Koronyo-Hamaoui M","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV et al (2011) Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage Jan 54(Suppl 1):S204\u2013S217. 10.1016\/j.neuroimage.2010.06.020","journal-title":"Neuroimage Jan"},{"issue":"1","key":"ref56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/ana.24548","article-title":"Melanopsin retinal ganglion cell loss in Alzheimer disease","volume":"79","author":"Morgia C","year":"2016","unstructured":"La Morgia C, Ross-Cisneros FN, Koronyo Y et al (2016) Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann Neurol Jan 79(1):90\u2013109. 10.1002\/ana.24548","journal-title":"Ann Neurol Jan"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3389\/fnins.2020.00758","article-title":"Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye","volume":"14","author":"Lee S","year":"2020","unstructured":"Lee S, Jiang K, McIlmoyle B et al (2020) Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye. Front Neurosci 14:758. 10.3389\/fnins.2020.00758","journal-title":"Front Neurosci"},{"issue":"1","key":"ref58","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13195-020-00715-1","article-title":"Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer's disease patients","volume":"10","author":"Lemmens S","year":"2020","unstructured":"Lemmens S, Van Craenendonck T, Van Eijgen J et al (2020) Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer's disease patients. Alzheimers Res Ther Nov 10(1):144. 10.1186\/s13195-020-00715-1","journal-title":"Alzheimers Res Ther Nov"},{"issue":"11","key":"ref59","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1021\/acschemneuro.9b00331","article-title":"In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease","volume":"20","author":"More SS","year":"2019","unstructured":"More SS, Beach JM, McClelland C, Mokhtarzadeh A, Vince R (2019) In Vivo Assessment of Retinal Biomarkers by Hyperspectral Imaging: Early Detection of Alzheimer's Disease. ACS Chem Neurosci Nov 20(11):4492\u20134501. 10.1021\/acschemneuro.9b00331","journal-title":"ACS Chem Neurosci Nov"},{"issue":"1","key":"ref60","doi-asserted-by":"publisher","first-page":"e12199","DOI":"10.1002\/dad2.12199","article-title":"Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial","volume":"13","author":"Ngolab J","year":"2021","unstructured":"Ngolab J, Donohue M, Belsha A et al (2021) Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. Alzheimers Dement (Amst) 13(1):e12199. 10.1002\/dad2.12199","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"ref61","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1167\/tvst.9.2.47","article-title":"Predicting Thioflavin Fluorescence of Retinal Amyloid Deposits Associated With Alzheimer's Disease from Their Polarimetric Properties","volume":"9","author":"Qiu Y","year":"2020","unstructured":"Qiu Y, Jin T, Mason E, Campbell MCW (2020) Predicting Thioflavin Fluorescence of Retinal Amyloid Deposits Associated With Alzheimer's Disease from Their Polarimetric Properties. Transl Vis Sci Technol Aug 9(2):47. 10.1167\/tvst.9.2.47","journal-title":"Transl Vis Sci Technol Aug"},{"issue":"12","key":"ref62","doi-asserted-by":"publisher","first-page":"e53547","DOI":"10.1371\/journal.pone.0053547","article-title":"Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice","volume":"7","author":"Schon C","year":"2012","unstructured":"Schon C, Hoffmann NA, Ochs SM et al (2012) Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS ONE 7(12):e53547. 10.1371\/journal.pone.0053547","journal-title":"PLoS ONE"},{"issue":"3","key":"ref63","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3233\/JAD-190868","article-title":"Levels of Retinal Amyloid-beta Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-beta in Neuropathologically Evaluated Individuals","volume":"73","author":"Schultz N","year":"2020","unstructured":"Schultz N, Byman E, Netherlands Brain B, Wennstrom M (2020) Levels of Retinal Amyloid-beta Correlate with Levels of Retinal IAPP and Hippocampal Amyloid-beta in Neuropathologically Evaluated Individuals. J Alzheimers Dis 73(3):1201\u20131209. 10.3233\/JAD-190868","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"ref64","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","article-title":"Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina","volume":"139","author":"Shi H","year":"2020","unstructured":"Shi H, Koronyo Y, Rentsendorj A et al (2020) Identification of early pericyte loss and vascular amyloidosis in Alzheimer's disease retina. Acta Neuropathol May 139(5):813\u2013836. 10.1007\/s00401-020-02134-w","journal-title":"Acta Neuropathol May"},{"issue":"2","key":"ref65","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3233\/JAD-210327","article-title":"Retinal Amyloid Imaging for Screening Alzheimer's Disease","volume":"83","author":"Tadokoro K","year":"2021","unstructured":"Tadokoro K, Yamashita T, Kimura S et al (2021) Retinal Amyloid Imaging for Screening Alzheimer's Disease. J Alzheimers Dis 83(2):927\u2013934. 10.3233\/JAD-210327","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"ref66","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1167\/iovs.13-12888","article-title":"Ocular changes in TgF344-AD rat model of Alzheimer's disease","volume":"29","author":"Tsai Y","year":"2014","unstructured":"Tsai Y, Lu B, Ljubimov AV et al (2014) Ocular changes in TgF344-AD rat model of Alzheimer's disease. Invest Ophthalmol Vis Sci Jan 29(1):523\u2013534. 10.1167\/iovs.13-12888","journal-title":"Invest Ophthalmol Vis Sci Jan"},{"issue":"1","key":"ref67","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","article-title":"Muller cell degeneration and microglial dysfunction in the Alzheimer's retina","volume":"5","author":"Xu QA","year":"2022","unstructured":"Xu QA, Boerkoel P, Hirsch-Reinshagen V et al (2022) Muller cell degeneration and microglial dysfunction in the Alzheimer's retina. Acta Neuropathol Commun Oct 5(1):145. 10.1186\/s40478-022-01448-y","journal-title":"Acta Neuropathol Commun Oct"},{"issue":"1","key":"ref68","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/alz.13424","article-title":"Primary retinal tauopathy: A tauopathy with a distinct molecular pattern","volume":"20","author":"Walkiewicz G","year":"2024","unstructured":"Walkiewicz G, Ronisz A, Van Ginderdeuren R et al (2024) Primary retinal tauopathy: A tauopathy with a distinct molecular pattern. Alzheimers Dement Jan 20(1):330\u2013340. 10.1002\/alz.13424","journal-title":"Alzheimers Dement Jan"},{"issue":"4","key":"ref69","doi-asserted-by":"publisher","first-page":"pgac164","DOI":"10.1093\/pnasnexus\/pgac164","article-title":"Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid beta-protein and phosphorylated tau","volume":"1","author":"Du X","year":"2022","unstructured":"Du X, Koronyo Y, Mirzaei N et al (2022) Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid beta-protein and phosphorylated tau. PNAS Nexus Sep 1(4):pgac164. 10.1093\/pnasnexus\/pgac164","journal-title":"PNAS Nexus Sep"},{"issue":"1","key":"ref70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-025-01935-y","article-title":"Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease","volume":"15","author":"Davis MR","year":"2025","unstructured":"Davis MR, Robinson E, Koronyo Y et al (2025) Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease. Acta Neuropathol Commun Feb 15(1):31. 10.1186\/s40478-025-01935-y","journal-title":"Acta Neuropathol Commun Feb"},{"issue":"1","key":"ref71","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00401-024-02760-8","article-title":"Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status","volume":"9","author":"Shi H","year":"2024","unstructured":"Shi H, Mirzaei N, Koronyo Y et al (2024) Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status. Acta Neuropathol Jul 9(1):3. 10.1007\/s00401-024-02760-8","journal-title":"Acta Neuropathol Jul"},{"issue":"48","key":"ref72","doi-asserted-by":"publisher","first-page":"30661","DOI":"10.1073\/pnas.2010943117","article-title":"Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics","volume":"1","author":"Hammer DX","year":"2020","unstructured":"Hammer DX, Agrawal A, Villanueva R, Saeedi O, Liu Z (2020) Label-free adaptive optics imaging of human retinal macrophage distribution and dynamics. Proc Natl Acad Sci U S A Dec 1(48):30661\u201330669. 10.1073\/pnas.2010943117","journal-title":"Proc Natl Acad Sci U S A Dec"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev-vision-030320-041255","article-title":"Cellular-Scale Imaging of Transparent Retinal Structures and Processes Using Adaptive Optics Optical Coherence Tomography","volume":"15","author":"Miller DT","year":"2020","unstructured":"Miller DT, Kurokawa K (2020) Cellular-Scale Imaging of Transparent Retinal Structures and Processes Using Adaptive Optics Optical Coherence Tomography. Annu Rev Vis Sci Sep 15:6:115\u2013148. 10.1146\/annurev-vision-030320-041255","journal-title":"Annu Rev Vis Sci Sep"},{"issue":"1","key":"ref74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13195-023-01375-7","article-title":"The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App(NL-F\/NL-F) mice","volume":"2","author":"Nunez-Diaz C","year":"2024","unstructured":"Nunez-Diaz C, Andersson E, Schultz N et al (2024) The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App(NL-F\/NL-F) mice. Alzheimers Res Ther Jan 2(1):4. 10.1186\/s13195-023-01375-7","journal-title":"Alzheimers Res Ther Jan"},{"issue":"7","key":"ref75","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1364\/OL.386454","article-title":"Imaging retinal structures at cellular-level resolution by visible-light optical coherence tomography","volume":"1","author":"Pi S","year":"2020","unstructured":"Pi S, Hormel TT, Wei X, Cepurna W, Morrison JC, Jia Y (2020) Imaging retinal structures at cellular-level resolution by visible-light optical coherence tomography. Opt Lett Apr 1(7):2107\u20132110. 10.1364\/OL.386454","journal-title":"Opt Lett Apr"},{"issue":"11","key":"ref76","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.1002\/alz.13086","article-title":"Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients","volume":"19","author":"Shi H","year":"2023","unstructured":"Shi H, Koronyo Y, Fuchs DT et al (2023) Retinal arterial Abeta(40) deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients. Alzheimers Dement Nov 19(11):5185\u20135197. 10.1002\/alz.13086","journal-title":"Alzheimers Dement Nov"},{"issue":"2","key":"ref77","doi-asserted-by":"publisher","first-page":"e12421","DOI":"10.1002\/dad2.12421","article-title":"Retinal imaging biomarkers of Alzheimer's disease: A systematic review and meta-analysis of studies using brain amyloid beta status for case definition. Alzheimers Dement (Amst)","volume":"15","author":"Ashraf G","year":"2023","unstructured":"Ashraf G, McGuinness M, Khan MA, Obtinalla C, Hadoux X, van Wijngaarden P (2023) Retinal imaging biomarkers of Alzheimer's disease: A systematic review and meta-analysis of studies using brain amyloid beta status for case definition. Alzheimers Dement (Amst). Apr-Jun 15(2):e12421. 10.1002\/dad2.12421","journal-title":"Apr-Jun"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"100899","DOI":"10.1016\/j.preteyeres.2020.100899","article-title":"Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances","volume":"82","author":"Gupta VB","year":"2021","unstructured":"Gupta VB, Chitranshi N, den Haan J et al (2021) Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res May 82:100899. 10.1016\/j.preteyeres.2020.100899","journal-title":"Prog Retin Eye Res May"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fnins.2020.00921","article-title":"Alzheimer's Retinopathy: Seeing Disease in the Eyes","volume":"14","author":"Mirzaei N","year":"2020","unstructured":"Mirzaei N, Shi H, Oviatt M et al (2020) Alzheimer's Retinopathy: Seeing Disease in the Eyes. Front Neurosci 14:921. 10.3389\/fnins.2020.00921","journal-title":"Front Neurosci"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"731614","DOI":"10.3389\/fnins.2021.731614","article-title":"Retinal Vasculopathy in Alzheimer's Disease","volume":"15","author":"Shi H","year":"2021","unstructured":"Shi H, Koronyo Y, Rentsendorj A et al (2021) Retinal Vasculopathy in Alzheimer's Disease. Front Neurosci 15:731614. 10.3389\/fnins.2021.731614","journal-title":"Front Neurosci"},{"issue":"1","key":"ref81","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/alz.12179","article-title":"Retinal imaging in Alzheimer's and neurodegenerative diseases","volume":"17","author":"Snyder PJ","year":"2021","unstructured":"Snyder PJ, Alber J, Alt C et al (2021) Retinal imaging in Alzheimer's and neurodegenerative diseases. Alzheimers Dement Jan 17(1):103\u2013111. 10.1002\/alz.12179","journal-title":"Alzheimers Dement Jan"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/alz.13529","article-title":"Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions","author":"Alber J","year":"2023","unstructured":"Alber J, Bouwman F, den Haan J et al (2023) Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions. Alzheimers Dement Nov 2. 10.1002\/alz.13529","journal-title":"Alzheimers Dement Nov 2"},{"issue":"4","key":"ref83","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/WAD.0000000000000279","article-title":"Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set","volume":"32","author":"Besser L","year":"2018","unstructured":"Besser L, Kukull W, Knopman DS et al (2018) Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. Alzheimer Dis Assoc Disord Oct-Dec 32(4):351\u2013358. 10.1097\/WAD.0000000000000279","journal-title":"Alzheimer Dis Assoc Disord Oct-Dec"},{"issue":"11","key":"ref84","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris JC","year":"1993","unstructured":"Morris JC (1993) The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology Nov 43(11):2412\u20132414. 10.1212\/wnl.43.11.2412-a","journal-title":"Neurology Nov"},{"issue":"4","key":"ref85","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine ZS","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, Bedirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc Apr 53(4):695\u2013699. 10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc Apr"},{"issue":"3","key":"ref86","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1080\/13854046.2022.2086487","article-title":"Classification statistics of the Montreal Cognitive Assessment (MoCA): Are we interpreting the MoCA correctly?","volume":"37","author":"Ratcliffe LN","year":"2023","unstructured":"Ratcliffe LN, McDonald T, Robinson B, Sass JR, Loring DW, Hewitt KC (2023) Classification statistics of the Montreal Cognitive Assessment (MoCA): Are we interpreting the MoCA correctly? Clin Neuropsychol Apr 37(3):562\u2013576. 10.1080\/13854046.2022.2086487","journal-title":"Clin Neuropsychol Apr"},{"issue":"3","key":"ref87","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein MF","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res Nov 12(3):189\u2013198. 10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res Nov"},{"issue":"12","key":"ref88","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/wnl.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"25","author":"Thal DR","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology Jun 25(12):1791\u20131800. 10.1212\/wnl.58.12.1791","journal-title":"Neurology Jun"},{"issue":"4","key":"ref89","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak H","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol Oct 112(4):389\u2013404. 10.1007\/s00401-006-0127-z","journal-title":"Acta Neuropathol Oct"},{"issue":"4","key":"ref90","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/wnl.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease","volume":"41","author":"Mirra SS","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology Apr 41(4):479\u2013486. 10.1212\/wnl.41.4.479","journal-title":"Neurology Apr"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4939-6740-7_5","article-title":"TMT One-Stop Shop: From Reliable Sample Preparation to Computational Analysis Platform","volume":"1549","author":"Mirzaei M","year":"2017","unstructured":"Mirzaei M, Pascovici D, Wu JX et al (2017) TMT One-Stop Shop: From Reliable Sample Preparation to Computational Analysis Platform. Methods Mol Biol 1549:45\u201366. 10.1007\/978-1-4939-6740-7_5","journal-title":"Methods Mol Biol"},{"issue":"6","key":"ref92","doi-asserted-by":"publisher","first-page":"e1004883","DOI":"10.1371\/journal.ppat.1004883","article-title":"The Proteome of the Isolated Chlamydia trachomatis Containing Vacuole Reveals a Complex Trafficking Platform Enriched for Retromer Components","volume":"11","author":"Aeberhard L","year":"2015","unstructured":"Aeberhard L, Banhart S, Fischer M et al (2015) The Proteome of the Isolated Chlamydia trachomatis Containing Vacuole Reveals a Complex Trafficking Platform Enriched for Retromer Components. PLoS Pathog Jun 11(6):e1004883. 10.1371\/journal.ppat.1004883","journal-title":"PLoS Pathog Jun"},{"issue":"4","key":"ref93","doi-asserted-by":"publisher","first-page":"e1007698","DOI":"10.1371\/journal.ppat.1007698","article-title":"Proximity-dependent proteomics of the Chlamydia trachomatis inclusion membrane reveals functional interactions with endoplasmic reticulum exit sites","volume":"15","author":"Dickinson MS","year":"2019","unstructured":"Dickinson MS, Anderson LN, Webb-Robertson BM et al (2019) Proximity-dependent proteomics of the Chlamydia trachomatis inclusion membrane reveals functional interactions with endoplasmic reticulum exit sites. PLoS Pathog Apr 15(4):e1007698. 10.1371\/journal.ppat.1007698","journal-title":"PLoS Pathog Apr"},{"issue":"1","key":"ref94","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.chom.2015.06.004","article-title":"Global Mapping of the Inc-Human Interactome Reveals that Retromer Restricts Chlamydia Infection","volume":"8","author":"Mirrashidi KM","year":"2015","unstructured":"Mirrashidi KM, Elwell CA, Verschueren E et al (2015) Global Mapping of the Inc-Human Interactome Reveals that Retromer Restricts Chlamydia Infection. Cell Host Microbe Jul 8(1):109\u2013121. 10.1016\/j.chom.2015.06.004","journal-title":"Cell Host Microbe Jul"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"103595","DOI":"10.1016\/j.jprot.2019.103595","article-title":"A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane","volume":"10","author":"Olson MG","year":"2020","unstructured":"Olson MG, Ouellette SP, Rucks EA (2020) A meta-analysis of affinity purification-mass spectrometry experimental systems used to identify eukaryotic and chlamydial proteins at the Chlamydia trachomatis inclusion membrane. J Proteomics Feb 10:212:103595. 10.1016\/j.jprot.2019.103595","journal-title":"J Proteomics Feb"},{"issue":"11","key":"ref96","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00537-19","article-title":"Proximity Labeling To Map Host-Pathogen Interactions at the Membrane of a Bacterium-Containing Vacuole in Chlamydia trachomatis-Infected Human Cells","volume":"87","author":"Olson MG","year":"2019","unstructured":"Olson MG, Widner RE, Jorgenson LM et al (2019) Proximity Labeling To Map Host-Pathogen Interactions at the Membrane of a Bacterium-Containing Vacuole in Chlamydia trachomatis-Infected Human Cells. Infect Immun Nov 87(11). 10.1128\/IAI.00537-19","journal-title":"Infect Immun Nov"},{"issue":"D1","key":"ref97","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"7","author":"Perez-Riverol Y","year":"2022","unstructured":"Perez-Riverol Y, Bai J, Bandla C et al (2022) The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res Jan 7(D1):D543\u2013D552. 10.1093\/nar\/gkab1038","journal-title":"Nucleic Acids Res Jan"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"Breiman L","year":"2001","unstructured":"Breiman L (2001) Random Forests. Mach Learn 45:5\u201332. 10.1023\/A:1010933404324","journal-title":"Mach Learn"},{"issue":"85","key":"ref99","first-page":"2825","article-title":"Scikit-learn: Machine Learning in Python","volume":"12","author":"Pedregosa FV","year":"2011","unstructured":"Pedregosa FV, Gramfort G, Michel A, Thirion V, Grisel B, Blondel O, Prettenhofer M, Weiss P, Dubourg R, Vanderplas V, Passos J, Cournapeau A, Brucher D, Perrot M, Duchesnay M (2011) Scikit-learn: Machine Learning in Python. J Mach Learn Res 12(85):2825\u20132830","journal-title":"J Mach Learn Res"},{"issue":"7825","key":"ref100","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris CR","year":"2020","unstructured":"Harris CR, Millman KJ, van der Walt SJ et al (2020) Array programming with NumPy. Nature Sep 585(7825):357\u2013362. 10.1038\/s41586-020-2649-2","journal-title":"Nature Sep"},{"key":"ref101","unstructured":"URL1"},{"issue":"3","key":"ref102","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen P","year":"2020","unstructured":"Virtanen P, Gommers R, Oliphant TE et al (2020) SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods Mar 17(3):261\u2013272. 10.1038\/s41592-019-0686-2","journal-title":"Nat Methods Mar"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1002\/9780471462422.eoct979","author":"Woolson RF","year":"2008","unstructured":"Woolson RF (2008) Wilcoxon Signed-Rank Test. In Wiley Encyclopedia of Clinical Trials (eds RB D'Agostino, L Sullivan and J Massaro). ;10.1002\/9780471462422.eoct979"},{"issue":"1","key":"ref104","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini YY","year":"1995","unstructured":"Benjamini YY (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Royal Stat Soc Ser B (Methodological) 57(1):289\u2013300","journal-title":"J Royal Stat Soc Ser B (Methodological)"},{"issue":"1","key":"ref105","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41467-024-54715-y","article-title":"Stereo-seq of the prefrontal cortex in aging and Alzheimer's disease","volume":"8","author":"Gong Y","year":"2025","unstructured":"Gong Y, Haeri M, Zhang X et al (2025) Stereo-seq of the prefrontal cortex in aging and Alzheimer's disease. Nat Commun Jan 8(1):482. 10.1038\/s41467-024-54715-y","journal-title":"Nat Commun Jan"},{"issue":"9","key":"ref106","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1001\/archneur.58.9.1403","article-title":"Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease","volume":"58","author":"Salat DH","year":"2001","unstructured":"Salat DH, Kaye JA, Janowsky JS (2001) Selective preservation and degeneration within the prefrontal cortex in aging and Alzheimer disease. Arch Neurol Sep 58(9):1403\u20131408. 10.1001\/archneur.58.9.1403","journal-title":"Arch Neurol Sep"},{"issue":"4","key":"ref107","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3233\/JAD-200303","article-title":"Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review","volume":"76","author":"Muzambi R","year":"2020","unstructured":"Muzambi R, Bhaskaran K, Brayne C, Davidson JA, Smeeth L, Warren-Gash C (2020) Common Bacterial Infections and Risk of Dementia or Cognitive Decline: A Systematic Review. J Alzheimers Dis 76(4):1609\u20131626. 10.3233\/JAD-200303","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"ref108","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.4049\/jimmunol.1901508","article-title":"IRF8 Regulates Gram-Negative Bacteria-Mediated NLRP3 Inflammasome Activation and Cell Death","volume":"1","author":"Karki R","year":"2020","unstructured":"Karki R, Lee E, Sharma BR, Banoth B, Kanneganti TD (2020) IRF8 Regulates Gram-Negative Bacteria-Mediated NLRP3 Inflammasome Activation and Cell Death. J Immunol May 1(9):2514\u20132522. 10.4049\/jimmunol.1901508","journal-title":"J Immunol May"},{"issue":"3","key":"ref109","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cell.2012.07.007","article-title":"TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria","volume":"150","author":"Rathinam VA","year":"2012","unstructured":"Rathinam VA, Vanaja SK, Waggoner L et al (2012) TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell Aug 3 150(3):606\u2013619. 10.1016\/j.cell.2012.07.007","journal-title":"Cell Aug 3"},{"issue":"6","key":"ref110","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.4049\/jimmunol.0802260","article-title":"Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins","volume":"15","author":"Dai P","year":"2009","unstructured":"Dai P, Jeong SY, Yu Y et al (2009) Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. J Immunol Mar 15(6):3450\u20133460. 10.4049\/jimmunol.0802260","journal-title":"J Immunol Mar"},{"issue":"17","key":"ref111","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713570","article-title":"In Silico Identification and Validation of Pyroptosis-Related Genes in Chlamydia Respiratory Infection","volume":"1","author":"Sun R","year":"2023","unstructured":"Sun R, Zheng W, Yang S et al (2023) In Silico Identification and Validation of Pyroptosis-Related Genes in Chlamydia Respiratory Infection. Int J Mol Sci Sep 1(17). 10.3390\/ijms241713570","journal-title":"Int J Mol Sci Sep"},{"issue":"3","key":"ref112","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.bbrc.2014.08.128","article-title":"Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated caspase-1 activation for optimal intracellular growth in murine macrophages","volume":"26","author":"Itoh R","year":"2014","unstructured":"Itoh R, Murakami I, Chou B et al (2014) Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated caspase-1 activation for optimal intracellular growth in murine macrophages. Biochem Biophys Res Commun Sep 26(3):689\u2013694. 10.1016\/j.bbrc.2014.08.128","journal-title":"Biochem Biophys Res Commun Sep"},{"issue":"3","key":"ref113","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.cmet.2018.05.027","article-title":"Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1beta Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis","volume":"4","author":"Tumurkhuu G","year":"2018","unstructured":"Tumurkhuu G, Dagvadorj J, Porritt RA et al (2018) Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1beta Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis. Cell Metab Sep 4(3):432\u2013448e4. 10.1016\/j.cmet.2018.05.027","journal-title":"Cell Metab Sep"},{"issue":"4","key":"ref114","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.neurobiolaging.2006.02.014","article-title":"Chlamydia pneumoniae infection of brain cells: an in vitro study","volume":"28","author":"Boelen E","year":"2007","unstructured":"Boelen E, Steinbusch HW, van der Ven AJ, Grauls G, Bruggeman CA, Stassen FR (2007) Chlamydia pneumoniae infection of brain cells: an in vitro study. Neurobiol Aging Apr 28(4):524\u2013532. 10.1016\/j.neurobiolaging.2006.02.014","journal-title":"Neurobiol Aging Apr"},{"issue":"36","key":"ref115","doi-asserted-by":"publisher","first-page":"13352","DOI":"10.1073\/pnas.0405479101","article-title":"Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration","volume":"7","author":"Cordeiro MF","year":"2004","unstructured":"Cordeiro MF, Guo L, Luong V et al (2004) Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A Sep 7(36):13352\u201313356. 10.1073\/pnas.0405479101","journal-title":"Proc Natl Acad Sci U S A Sep"},{"issue":"1","key":"ref116","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s40478-024-01810-2","article-title":"Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial","volume":"28","author":"Dumitrascu OM","year":"2024","unstructured":"Dumitrascu OM, Doustar J, Fuchs DT et al (2024) Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial. Acta Neuropathol Commun Jun 28(1):109. 10.1186\/s40478-024-01810-2","journal-title":"Acta Neuropathol Commun Jun"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1533317519899800","DOI":"10.1177\/1533317519899800","article-title":"Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment","volume":"35","author":"Kile S","year":"2020","unstructured":"Kile S, Au W, Parise C et al (2020) Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment. Am J Alzheimers Dis Other Demen Jan-Dec 35:1533317519899800. 10.1177\/1533317519899800","journal-title":"Am J Alzheimers Dis Other Demen Jan-Dec"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-4939-2152-2_17","article-title":"Real-time imaging of retinal cell apoptosis by confocal scanning laser ophthalmoscopy","volume":"1254","author":"Normando EM","year":"2015","unstructured":"Normando EM, Dehabadi MH, Guo L, Turner LA, Pollorsi G, Cordeiro MF (2015) Real-time imaging of retinal cell apoptosis by confocal scanning laser ophthalmoscopy. Methods Mol Biol 1254:227\u2013237. 10.1007\/978-1-4939-2152-2_17","journal-title":"Methods Mol Biol"},{"issue":"6","key":"ref119","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1167\/iovs.07-1335","article-title":"Real-time in vivo imaging of retinal cell apoptosis after laser exposure","volume":"49","author":"Schmitz-Valckenberg S","year":"2008","unstructured":"Schmitz-Valckenberg S, Guo L, Maass A et al (2008) Real-time in vivo imaging of retinal cell apoptosis after laser exposure. Invest Ophthalmol Vis Sci Jun 49(6):2773\u20132780. 10.1167\/iovs.07-1335","journal-title":"Invest Ophthalmol Vis Sci Jun"},{"issue":"6","key":"ref120","doi-asserted-by":"publisher","DOI":"10.3390\/cells7060060","article-title":"Real-Time Imaging of Retinal Ganglion Cell Apoptosis","volume":"15","author":"Yap TE","year":"2018","unstructured":"Yap TE, Donna P, Almonte MT, Cordeiro MF (2018) Real-Time Imaging of Retinal Ganglion Cell Apoptosis. Cells Jun 15(6). 10.3390\/cells7060060","journal-title":"Cells Jun"},{"issue":"12","key":"ref121","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1111\/ene.12477","article-title":"A study on the association between infectious burden and Alzheimer's disease","volume":"22","author":"Bu XL","year":"2015","unstructured":"Bu XL, Yao XQ, Jiao SS et al (2015) A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol Dec 22(12):1519\u20131525. 10.1111\/ene.12477","journal-title":"Eur J Neurol Dec"},{"issue":"1\u20132","key":"ref122","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.micpath.2005.05.002","article-title":"The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog","volume":"39","author":"Gerard HC","year":"2005","unstructured":"Gerard HC, Wildt KL, Whittum-Hudson JA, Lai Z, Ager J, Hudson AP (2005) The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype. Microb Pathog. Jul-Aug 39(1\u20132):19\u201326. 10.1016\/j.micpath.2005.05.002","journal-title":"Jul-Aug"},{"issue":"1","key":"ref123","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/ADR-210008","article-title":"Plasma Amyloid-beta in Relation to Antibodies Against Herpes Simplex Virus, Cytomegalovirus, and Chlamydophila pneumoniae","volume":"6","author":"Lopatko Lindman K","year":"2021","unstructured":"Lopatko Lindman K, Weidung B, Olsson J et al (2021) Plasma Amyloid-beta in Relation to Antibodies Against Herpes Simplex Virus, Cytomegalovirus, and Chlamydophila pneumoniae. J Alzheimers Dis Rep Apr 6(1):229\u2013235. 10.3233\/ADR-210008","journal-title":"J Alzheimers Dis Rep Apr"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(00)83440-5","article-title":"Identification of Chlamydia pneumoniae in the Alzheimer's brain","volume":"21","author":"Mahony JB","year":"2000","unstructured":"Mahony JB, WJ, Munoz D, Browning D, Chong S, Smieja M (2000) Identification of Chlamydia pneumoniae in the Alzheimer's brain. Neurobiol Aging 21:245. 10.1016\/S0197-4580(00)83440-5","journal-title":"Neurobiol Aging"},{"issue":"4","key":"ref125","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1532-5415.2005.53204.x","article-title":"High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia","volume":"53","author":"Yamamoto H","year":"2005","unstructured":"Yamamoto H, Watanabe T, Miyazaki A et al (2005) High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia. J Am Geriatr Soc Apr 53(4):583\u2013589. 10.1111\/j.1532-5415.2005.53204.x","journal-title":"J Am Geriatr Soc Apr"},{"issue":"4","key":"ref126","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1128\/CMR.8.4.451","article-title":"Chlamydia pneumoniae (TWAR)","volume":"8","author":"Kuo CC","year":"1995","unstructured":"Kuo CC, Jackson LA, Campbell LA, Grayston JT (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev Oct 8(4):451\u2013461. 10.1128\/CMR.8.4.451","journal-title":"Clin Microbiol Rev Oct"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.3389\/fmicb.2018.03101","article-title":"Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo","volume":"9","author":"Panzetta ME","year":"2018","unstructured":"Panzetta ME, Valdivia RH, Saka HA (2018) Chlamydia Persistence: A Survival Strategy to Evade Antimicrobial Effects in-vitro and in-vivo. Front Microbiol 9:3101. 10.3389\/fmicb.2018.03101","journal-title":"Front Microbiol"},{"issue":"2","key":"ref128","doi-asserted-by":"publisher","first-page":"e0033923","DOI":"10.1128\/iai.00339-23","article-title":"Metabolic dormancy in Chlamydia trachomatis treated with different antibiotics","volume":"13","author":"Rockey DD","year":"2024","unstructured":"Rockey DD, Wang X, Debrine A, Grieshaber N, Grieshaber SS (2024) Metabolic dormancy in Chlamydia trachomatis treated with different antibiotics. Infect Immun Feb 13(2):e0033923. 10.1128\/iai.00339-23","journal-title":"Infect Immun Feb"},{"issue":"1","key":"ref129","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-022-00359-5","article-title":"Trachoma","volume":"26","author":"Solomon AW","year":"2022","unstructured":"Solomon AW, Burton MJ, Gower EW et al (2022) Trachoma. Nat Rev Dis Primers May 26(1):32. 10.1038\/s41572-022-00359-5","journal-title":"Nat Rev Dis Primers May"},{"issue":"11","key":"ref130","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","article-title":"Alzheimer's disease: A matter of blood-brain barrier dysfunction?","volume":"6","author":"Montagne A","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV (2017) Alzheimer's disease: A matter of blood-brain barrier dysfunction? J Exp Med Nov 6(11):3151\u20133169. 10.1084\/jem.20171406","journal-title":"J Exp Med Nov"},{"issue":"12","key":"ref131","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders","volume":"3","author":"Zlokovic BV","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci Nov 3(12):723\u2013738. 10.1038\/nrn3114","journal-title":"Nat Rev Neurosci Nov"},{"issue":"2","key":"ref132","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jalz.2013.06.009","article-title":"Microvascular network alterations in the retina of patients with Alzheimer's disease","volume":"10","author":"Cheung CY","year":"2014","unstructured":"Cheung CY, Ong YT, Ikram MK et al (2014) Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimers Dement Mar 10(2):135\u2013142. 10.1016\/j.jalz.2013.06.009","journal-title":"Alzheimers Dement Mar"},{"issue":"1","key":"ref133","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13195-020-00724-0","article-title":"Retinal microvasculature dysfunction is associated with Alzheimer's disease and mild cognitive impairment","volume":"4","author":"Chua J","year":"2020","unstructured":"Chua J, Hu Q, Ke M et al (2020) Retinal microvasculature dysfunction is associated with Alzheimer's disease and mild cognitive impairment. Alzheimers Res Ther Dec 4(1):161. 10.1186\/s13195-020-00724-0","journal-title":"Alzheimers Res Ther Dec"},{"issue":"1","key":"ref134","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13195-024-01668-5","article-title":"Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease","volume":"10","author":"Ravichandran S","year":"2025","unstructured":"Ravichandran S, Snyder PJ, Alber J et al (2025) Association and multimodal model of retinal and blood-based biomarkers for detection of preclinical Alzheimer's disease. Alzheimers Res Ther Jan 10(1):19. 10.1186\/s13195-024-01668-5","journal-title":"Alzheimers Res Ther Jan"},{"issue":"1","key":"ref135","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s40478-020-01076-4","article-title":"Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease","volume":"23","author":"Shi H","year":"2020","unstructured":"Shi H, Koronyo Y, Fuchs DT et al (2020) Retinal capillary degeneration and blood-retinal barrier disruption in murine models of Alzheimer's disease. Acta Neuropathol Commun Nov 23(1):202. 10.1186\/s40478-020-01076-4","journal-title":"Acta Neuropathol Commun Nov"},{"issue":"1","key":"ref136","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s40478-022-01439-z","article-title":"Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer's-induced retinal vasculopathy by limiting Clec7a\/Galectin-3(+) neurodegenerative microglia","volume":"8","author":"Shi H","year":"2022","unstructured":"Shi H, Yin Z, Koronyo Y et al (2022) Regulating microglial miR-155 transcriptional phenotype alleviates Alzheimer's-induced retinal vasculopathy by limiting Clec7a\/Galectin-3(+) neurodegenerative microglia. Acta Neuropathol Commun Sep 8(1):136. 10.1186\/s40478-022-01439-z","journal-title":"Acta Neuropathol Commun Sep"},{"issue":"2","key":"ref137","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1148\/radiol.2016152244","article-title":"Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease","volume":"281","author":"Haar HJ","year":"2016","unstructured":"van de Haar HJ, Burgmans S, Jansen JF et al (2016) Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease. Radiology Nov 281(2):527\u2013535. 10.1148\/radiol.2016152244","journal-title":"Radiology Nov"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"860759","DOI":"10.3389\/fnagi.2022.860759","article-title":"Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression","volume":"14","author":"Yeh TC","year":"2022","unstructured":"Yeh TC, Kuo CT, Chou YB (2022) Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression. Front Aging Neurosci 14:860759. 10.3389\/fnagi.2022.860759","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"ref139","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2217\/nmt-2016-0035","article-title":"Alzheimer's disease: the potential therapeutic role of the natural antibiotic amyloid-beta peptide","volume":"6","author":"Kumar DK","year":"2016","unstructured":"Kumar DK, Eimer WA, Tanzi RE, Moir RD (2016) Alzheimer's disease: the potential therapeutic role of the natural antibiotic amyloid-beta peptide. Neurodegener Dis Manag Oct 6(5):345\u2013348. 10.2217\/nmt-2016-0035","journal-title":"Neurodegener Dis Manag Oct"},{"issue":"12","key":"ref140","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","article-title":"The antimicrobial protection hypothesis of Alzheimer's disease","volume":"14","author":"Moir RD","year":"2018","unstructured":"Moir RD, Lathe R, Tanzi RE (2018) The antimicrobial protection hypothesis of Alzheimer's disease. Alzheimers Dement Dec 14(12):1602\u20131614. 10.1016\/j.jalz.2018.06.3040","journal-title":"Alzheimers Dement Dec"},{"issue":"3","key":"ref141","doi-asserted-by":"publisher","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide","volume":"3","author":"Soscia SJ","year":"2010","unstructured":"Soscia SJ, Kirby JE, Washicosky KJ et al (2010) The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One Mar 3(3):e9505. 10.1371\/journal.pone.0009505","journal-title":"PLoS One Mar"},{"issue":"8006","key":"ref142","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","article-title":"APOE4\/4 is linked to damaging lipid droplets in Alzheimer's disease microglia","volume":"628","author":"Haney MS","year":"2024","unstructured":"Haney MS, Palovics R, Munson CN et al (2024) APOE4\/4 is linked to damaging lipid droplets in Alzheimer's disease microglia. Nature Apr 628(8006):154\u2013161. 10.1038\/s41586-024-07185-7","journal-title":"Nature Apr"},{"issue":"11","key":"ref143","doi-asserted-by":"publisher","first-page":"739","DOI":"10.14348\/molcells.2019.0200","article-title":"ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease","volume":"30","author":"Jeong W","year":"2019","unstructured":"Jeong W, Lee H, Cho S, Seo J (2019) ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer's Disease. Mol Cells Nov 30(11):739\u2013746. 10.14348\/molcells.2019.0200","journal-title":"Mol Cells Nov"},{"issue":"14","key":"ref144","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jacc.2018.01.072","article-title":"Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis","volume":"10","author":"Chen S","year":"2018","unstructured":"Chen S, Shimada K, Crother TR, Erbay E, Shah PK, Arditi M (2018) Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis. J Am Coll Cardiol Apr 10(14):1553\u20131570. 10.1016\/j.jacc.2018.01.072","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"ref145","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.4049\/jimmunol.181.10.7176","article-title":"TLR\/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis","volume":"15","author":"Naiki Y","year":"2008","unstructured":"Naiki Y, Sorrentino R, Wong MH et al (2008) TLR\/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. J Immunol Nov 15(10):7176\u20137185. 10.4049\/jimmunol.181.10.7176","journal-title":"J Immunol Nov"},{"issue":"1","key":"ref146","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cellimm.2015.01.007","article-title":"A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice","volume":"294","author":"Sorrentino R","year":"2015","unstructured":"Sorrentino R, Yilmaz A, Schubert K et al (2015) A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice. Cell Immunol Mar 294(1):25\u201332. 10.1016\/j.cellimm.2015.01.007","journal-title":"Cell Immunol Mar"},{"issue":"10","key":"ref147","doi-asserted-by":"publisher","first-page":"e1186","DOI":"10.1002\/cti2.1186","article-title":"Emerging insights on the role of gasdermins in infection and inflammatory diseases","volume":"9","author":"Tang L","year":"2020","unstructured":"Tang L, Lu C, Zheng G, Burgering BM (2020) Emerging insights on the role of gasdermins in infection and inflammatory diseases. Clin Transl Immunol 9(10):e1186. 10.1002\/cti2.1186","journal-title":"Clin Transl Immunol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04758-z","article-title":"Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy\/Mitophagy to Therapeutics","volume":"14","author":"Ayyubova G","year":"2025","unstructured":"Ayyubova G, Madhu LN (2025) Microglial NLRP3 Inflammasomes in Alzheimer's Disease Pathogenesis: From Interaction with Autophagy\/Mitophagy to Therapeutics. Mol Neurobiol Feb 14. 10.1007\/s12035-025-04758-z","journal-title":"Mol Neurobiol Feb"},{"issue":"2","key":"ref149","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/cmi.2015.95","article-title":"Molecular mechanisms regulating NLRP3 inflammasome activation","volume":"13","author":"Jo EK","year":"2016","unstructured":"Jo EK, Kim JK, Shin DM, Sasakawa C (2016) Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol Mar 13(2):148\u2013159. 10.1038\/cmi.2015.95","journal-title":"Cell Mol Immunol Mar"},{"issue":"2","key":"ref150","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"12","author":"Yang Y","year":"2019","unstructured":"Yang Y, Wang H, Kouadir M, Song H, Shi F (2019) Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death Dis Feb 12(2):128. 10.1038\/s41419-019-1413-8","journal-title":"Cell Death Dis Feb"},{"issue":"9","key":"ref151","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00011-023-01790-4","article-title":"Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases","volume":"72","author":"Han YH","year":"2023","unstructured":"Han YH, Liu XD, Jin MH, Sun HN, Kwon T (2023) Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases. Inflamm Res Sep 72(9):1839\u20131859. 10.1007\/s00011-023-01790-4","journal-title":"Inflamm Res Sep"},{"issue":"3","key":"ref152","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3233\/JAD-210268","article-title":"NLRP3 Inflammasome: A Starring Role in Amyloid-beta- and Tau-Driven Pathological Events in Alzheimer's Disease","volume":"83","author":"Zeller M","year":"2021","unstructured":"Van Zeller M, Dias D, Sebastiao AM, Valente CA (2021) NLRP3 Inflammasome: A Starring Role in Amyloid-beta- and Tau-Driven Pathological Events in Alzheimer's Disease. J Alzheimers Dis 83(3):939\u2013961. 10.3233\/JAD-210268","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"ref153","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1038\/s41380-023-02239-0","article-title":"Targeting NLRP3 inflammasome for neurodegenerative disorders","volume":"28","author":"Yao J","year":"2023","unstructured":"Yao J, Wang Z, Song W, Zhang Y (2023) Targeting NLRP3 inflammasome for neurodegenerative disorders. Mol Psychiatry Nov 28(11):4512\u20134527. 10.1038\/s41380-023-02239-0","journal-title":"Mol Psychiatry Nov"},{"key":"ref154","article-title":"The inflammatory aspects of Chlamydia pneumoniae-induced brain infection","author":"Boelen E","unstructured":"Boelen E, Steinbusch HW, Bruggeman CA, Stassen FR The inflammatory aspects of Chlamydia pneumoniae-induced brain infection. Drugs Today (Barc). Nov 2009;45 Suppl B:159\u2009\u2013\u200964.","journal-title":"Drugs Today (Barc)"},{"key":"ref155","doi-asserted-by":"publisher","first-page":"1513095","DOI":"10.3389\/fnins.2024.1513095","article-title":"Alzheimer's disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles","volume":"18","author":"Hosseininasab SSM","year":"2024","unstructured":"Hosseininasab SSM, Ebrahimi R, Yaghoobpoor S et al (2024) Alzheimer's disease and infectious agents: a comprehensive review of pathogenic mechanisms and microRNA roles. Front Neurosci 18:1513095. 10.3389\/fnins.2024.1513095","journal-title":"Front Neurosci"},{"issue":"11","key":"ref156","doi-asserted-by":"publisher","first-page":"e0260633","DOI":"10.1371\/journal.pone.0260633","article-title":"Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model","volume":"16","author":"Kaya-Tilki E","year":"2021","unstructured":"Kaya-Tilki E, Dikmen M (2021) Neuroprotective effects of some epigenetic modifying drugs' on Chlamydia pneumoniae-induced neuroinflammation: A novel model. PLoS ONE 16(11):e0260633. 10.1371\/journal.pone.0260633","journal-title":"PLoS ONE"},{"key":"ref157","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12974-014-0217-0","article-title":"Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease","volume":"11","author":"Lim C","year":"2014","unstructured":"Lim C, Hammond CJ, Hingley ST, Balin BJ (2014) Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease. J Neuroinflammation Dec 24 11:217. 10.1186\/s12974-014-0217-0","journal-title":"J Neuroinflammation Dec 24"},{"issue":"5","key":"ref158","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/jnr.10519","article-title":"Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells","volume":"1","author":"MacIntyre A","year":"2003","unstructured":"MacIntyre A, Abramov R, Hammond CJ et al (2003) Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res Mar 1(5):740\u2013750. 10.1002\/jnr.10519","journal-title":"J Neurosci Res Mar"},{"issue":"2","key":"ref159","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3233\/JAD-140348","article-title":"Modulation of amyloid-beta protein precursor expression by HspB1","volume":"42","author":"Conway M","year":"2014","unstructured":"Conway M, Nafar F, Straka T, Mearow K (2014) Modulation of amyloid-beta protein precursor expression by HspB1. J Alzheimers Dis 42(2):435\u2013450. 10.3233\/JAD-140348","journal-title":"J Alzheimers Dis"},{"issue":"22","key":"ref160","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225281","article-title":"The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases","volume":"13","author":"Kulczynska-Przybik A","year":"2021","unstructured":"Kulczynska-Przybik A, Dulewicz M, Slowik A et al (2021) The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases. J Clin Med Nov 13(22). 10.3390\/jcm10225281","journal-title":"J Clin Med Nov"},{"issue":"3","key":"ref161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030908","article-title":"Dendritic Spines in Alzheimer's Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure","volume":"30","author":"Pelucchi S","year":"2020","unstructured":"Pelucchi S, Stringhi R, Marcello E (2020) Dendritic Spines in Alzheimer's Disease: How the Actin Cytoskeleton Contributes to Synaptic Failure. Int J Mol Sci Jan 30(3). 10.3390\/ijms21030908","journal-title":"Int J Mol Sci Jan"},{"issue":"12","key":"ref162","doi-asserted-by":"publisher","first-page":"eadk9884","DOI":"10.1126\/sciadv.adk9884","article-title":"Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection","volume":"22","author":"Yang F","year":"2024","unstructured":"Yang F, Beltran-Lobo P, Sung K et al (2024) Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection. Sci Adv Mar 22(12):eadk9884. 10.1126\/sciadv.adk9884","journal-title":"Sci Adv Mar"},{"key":"ref163","doi-asserted-by":"publisher","first-page":"1049786","DOI":"10.3389\/fgene.2022.1049786","article-title":"Bioinformatics-based study reveals that AP2M1 is regulated by the circRNA-miRNA-mRNA interaction network and affects Alzheimer's disease","volume":"13","author":"Zhang Q","year":"2022","unstructured":"Zhang Q, Chen B, Yang P, Wu J, Pang X, Pang C (2022) Bioinformatics-based study reveals that AP2M1 is regulated by the circRNA-miRNA-mRNA interaction network and affects Alzheimer's disease. Front Genet 13:1049786. 10.3389\/fgene.2022.1049786","journal-title":"Front Genet"},{"issue":"3","key":"ref164","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1128\/IAI.73.3.1861-1864.2005","article-title":"Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells","volume":"73","author":"Dong F","year":"2005","unstructured":"Dong F, Pirbhai M, Xiao Y, Zhong Y, Wu Y, Zhong G (2005) Degradation of the proapoptotic proteins Bik, Puma, and Bim with Bcl-2 domain 3 homology in Chlamydia trachomatis-infected cells. Infect Immun Mar 73(3):1861\u20131864. 10.1128\/IAI.73.3.1861-1864.2005","journal-title":"Infect Immun Mar"},{"issue":"6","key":"ref165","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","article-title":"Chlamydia cell biology and pathogenesis","volume":"14","author":"Elwell C","year":"2016","unstructured":"Elwell C, Mirrashidi K, Engel J (2016) Chlamydia cell biology and pathogenesis. Nat Rev Microbiol Jun 14(6):385\u2013400. 10.1038\/nrmicro.2016.30","journal-title":"Nat Rev Microbiol Jun"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6658954\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6658954\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:06:49Z","timestamp":1769155609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6658954\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":165,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6658954\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41467-026-68580-4","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,6,26]]},"subtype":"preprint"}}